Clinical safety study of Menggenwusu -18 pill on psoriasis patients
10.13699/j.cnki.1001-6821.2014.10.012
- VernacularTitle:孟根乌苏-18味丸对银屑病患者安全性研究
- Author:
Yu QING
1
;
Zhi-Qiang HAN
;
Deligen BATU
;
Yun WU
Author Information
1. 内蒙古民族大学附属医院 蒙药药理研究所
- Keywords:
Menggenwusu -18 pill;
security;
clinical study
- From:
The Chinese Journal of Clinical Pharmacology
2014;(10):909-911
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the safety of Menggenwusu -18 pill on psoriasis patients.Methods Thirty -six cases of psoriasis patients were given Menggenwusu -18 pills, 9 to 11 pills once a day at a night for 28 days.The vital signs, adverse drug reactions, urine and blood rou-tine, ECG and blood biochemical parameters were recorded before and after the experiment.Results Thirty -six patients had no significant adverse reactions and the data of vital signs ,ECG,urine and blood rou-tine, liver and kidney function all were normal.Conclusion Menggen-wusu -18 pill is well tolerated by psoriasis patients.Clinical prescribed dose at range of 9 to 11 pills is recommended.
